Bank of America’s BioSpecifics Technologies Corp. BSTC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-2,208
| Closed | -$116K | – | 7570 |
|
|
2020
Q3 | $116K | Sell |
2,208
-1,053
| -32% | -$65K | ﹤0.01% | 5615 |
|
|
2020
Q2 | $200K | Buy |
3,261
+302
| +10% | +$17.5K | ﹤0.01% | 5245 |
|
|
2020
Q1 | $168K | Sell |
2,959
-555
| -16% | -$31.6K | ﹤0.01% | 5195 |
|
|
2019
Q4 | $200K | Sell |
3,514
-1,063
| -23% | -$56.4K | ﹤0.01% | 5640 |
|
|
2019
Q3 | $245K | Buy |
4,577
+310
| +7% | +$18K | ﹤0.01% | 5541 |
|
|
2019
Q2 | $255K | Buy |
4,267
+1,444
| +51% | +$90.9K | ﹤0.01% | 5496 |
|
|
2019
Q1 | $176K | Sell |
2,823
-1,597
| -36% | -$106K | ﹤0.01% | 5589 |
|
|
2018
Q4 | $267K | Sell |
4,420
-1,516
| -26% | -$90.6K | ﹤0.01% | 5339 |
|
|
2018
Q3 | $347K | Buy |
5,936
+1,850
| +45% | +$94.4K | ﹤0.01% | 5179 |
|
|
2018
Q2 | $183K | Buy |
4,086
+3,365
| +467% | +$145K | ﹤0.01% | 5465 |
|
|
2018
Q1 | $32K | Sell |
721
-294
| -29% | -$12.3K | ﹤0.01% | 6216 |
|
|
2017
Q4 | $44K | Buy |
1,015
+213
| +27% | +$9.57K | ﹤0.01% | 6117 |
|
|
2017
Q3 | $38K | Buy |
802
+410
| +105% | +$19.6K | ﹤0.01% | 6052 |
|
|
2017
Q2 | $20K | Sell |
392
-2,097
| -84% | -$110K | ﹤0.01% | 6233 |
|
|
2017
Q1 | $137K | Buy |
2,489
+1,371
| +123% | +$72.6K | ﹤0.01% | 5489 |
|
|
2016
Q4 | $62K | Sell |
1,118
-6
| -0.5% | -$288 | ﹤0.01% | 5843 |
|
|
2016
Q3 | $51K | Buy |
1,124
+647
| +136% | +$26K | ﹤0.01% | 5728 |
|
|
2016
Q2 | $19K | Buy |
477
+377
| +377% | +$13.8K | ﹤0.01% | 6277 |
|
|
2016
Q1 | $3K | Sell |
100
-1,227
| -92% | -$45K | ﹤0.01% | 6724 |
|
|
2015
Q4 | $57K | Buy |
1,327
+1,196
| +913% | +$59.9K | ﹤0.01% | 5991 |
|
|
2015
Q3 | $5K | Sell |
131
-48
| -27% | -$2.59K | ﹤0.01% | 6767 |
|
|
2015
Q2 | $9K | Buy |
+179
| New | +$7.63K | ﹤0.01% | 6633 |
|
|
2015
Q1 | – | Sell |
-1,400
| Closed | -$54K | – | 7751 |
|
|
2014
Q4 | $54K | Buy |
1,400
+500
| +56% | +$19.1K | ﹤0.01% | 6297 |
|
|
2014
Q3 | $32K | Buy |
+900
| New | +$26.4K | ﹤0.01% | 6801 |
|
|
2014
Q1 | – | Sell |
-230
| Closed | -$5K | – | 8232 |
|
|
2013
Q4 | $5K | Sell |
230
-340
| -60% | -$6.96K | ﹤0.01% | 7479 |
|
|
2013
Q3 | $11K | Sell |
570
-9,518
| -94% | -$169K | ﹤0.01% | 7148 |
|
|
2013
Q2 | $157K | Buy |
+10,088
| New | +$162K | ﹤0.01% | 5843 |
|
Other funds holding BSTC
Bank of America's BSTC Position: Q4 2020 in Review
Bank of America sold out of BioSpecifics Technologies Corp. (BSTC) in Q4 2020, closing a stake of 2,208 shares — an estimated $116K sold.
Bank of America first reported a position in BSTC in Q2 2013 and held it in 27 quarters. The position peaked at $347K in Q3 2018. 1 fund tracked by Wall St. Rank holds BSTC as of Q4 2020.
- Bank of America reported no remaining BioSpecifics Technologies Corp. position as of Q4 2020 after selling out during the quarter.
- Bank of America sold 2,208 BioSpecifics Technologies Corp. shares in Q4 2020, an estimated $116K.
- Bank of America first reported a position in BioSpecifics Technologies Corp. in Q2 2013 and held it in 27 quarters.
- Bank of America's BioSpecifics Technologies Corp. position peaked at $347K in Q3 2018.
- 1 fund tracked by Wall St. Rank held BioSpecifics Technologies Corp. as of Q4 2020.
Based on Bank of America's 13F filing for Q4 2020, filed 10 Feb 2021.